Genoloam Enters Into Partnership With BIO3S and Becomes the Official Sales Partner in Europe

November 3, 2021

On 3rd of November 2021, GENOLOAM and BIO3S held a signing ceremony in which GENOLOAM was appointed as an official sales representative in Europe for the innovative products by BIO3S. BIO3S is a leading healthcare company in South Korea, and their latest innovation BeanGuard Gargle Technology was developed with the aim to ease and quicken the process of PCR testing for COVID-19. GENOLOAM will be distributing the OVC-based Antigen COVID-19 self-test kit, which is known to be as accurate as the PCR test. Their innovative Oral Virus Clinical Collection Technology (OVC) helps to collect more of the virus located in the oral cavity with highly accurate results and in less than 15 minutes. Due to the easy self-collection method, no medical staff is required at the sample collection center and this will lower the burden and cost of the lab operation. GENOLOAM is extremely proud of the partnership with BIO3S and wishes for a long and fruitful collaboration.

Previous
Previous

Optolane Acquires European CE-IVD Certification for 30-Minute Ultra-Fast PCR Diagnostic Device

Next
Next

EMA Receives Application for Marketing Authorisation for Regkirona (Regdanvimab) Medicine for Treating Patients With COVID-19